Filter

111 - 120 of 372 Results

  • Assessing the Role of Treaties, Conventions, Institutions, and Other International Agreements in the Global COVID-19 Response: Implications for the Future

    Issue Brief

    This issue brief examines existing treaties and other global health agreements to assess whether they have been utilized for the COVID-19 pandemic response and whether they contain pandemic preparedness and response components in their mandates. The COVID-19 pandemic challenged and revealed gaps in global health governance systems, prompting stakeholders to reevaluate existing frameworks and discuss new agreements aimed at addressing future pandemics. To help inform these discussions, we evaluate existing global health agreements to assess their role in pandemic preparedness and response efforts, including the COVID-19 pandemic.

  • Global Health Funding in the FY 2023 Omnibus

    Fact Sheet

    Updated on January 3, 2023 The FY 2023 Omnibus appropriations bill and accompanying reports, released by Congress on December 20, 2022, and signed by the President on December 29, 2022, includes funding for

  • Why Do Vaccinated People Represent Most COVID-19 Deaths Right Now?

    Policy Watch

    This post explores why the share of COVID-19 deaths among those who are vaccinated has risen, Factors include a rising share of the population that is vaccinated, waning immune protection and low uptake of boosters, and changes in immunity among the unvaccinated.

  • The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

    Issue Brief

    In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to vaccines and funding, and difficult and complex application, review, and implementation processes. We discuss these challenges and also consider implications of the Buffer experience for future pandemic preparedness and response efforts.

  • Donor Government Funding for Family Planning in 2021

    Report

    In 2021, donor government funding for family planning activities totaled US$1.39 billion, essentially flat compared to the 2020 amount (US$1.41 billion). This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2021.

  • Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States

    Issue Brief

    This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.